Behind every shocking headline about addiction, from the millions caught in the grip of prescription painkillers to the billions lost in economic fallout, lies a complex human story written in statistics like these.
Key Takeaways
- In 2022, 70.4 million people aged 12 or older (24.9% of the U.S. population) reported past year misuse of prescription pain relievers
- Globally, 296 million people used cannabis in 2021, representing 5.8% of the adult population aged 15-64
- In the United States, 48.7 million people aged 12 or older (17.3%) used illicit drugs in the past year in 2022
- Fentanyl-involved overdose deaths rose 22% from 2021 to 2022, totaling 73,838 in the U.S.
- Opioid use disorder led to 81,806 overdose deaths in the U.S. in 2022
- Methamphetamine-involved overdose deaths increased to 36,466 in the U.S. in 2022
- Illicit drug use costs the U.S. $740 billion annually in healthcare, crime, and lost productivity
- Opioid crisis economic burden: $1.02 trillion in U.S. from 2015-2020
- Alcohol misuse costs U.S. $249 billion yearly in healthcare and lost productivity
- 28.3 million people aged 12+ had substance use disorder in U.S. 2022
- Only 21.2% of people with opioid use disorder received medications for addiction in 2021
- Methamphetamine use disorder treatment completion rate: 40-60% with contingency management
- U.S. federal drug arrests totaled 1.2 million in 2022, mostly possession
- 42 U.S. states legalized medical cannabis by 2023, covering 93% population
- DEA Schedule I drugs include heroin, LSD, marijuana, ecstasy per Controlled Substances Act
Millions of people misuse substances globally, resulting in addiction and death.
Addiction and Treatment
128.3 million people aged 12+ had substance use disorder in U.S. 2022
Verified2Only 21.2% of people with opioid use disorder received medications for addiction in 2021
Verified3Methamphetamine use disorder treatment completion rate: 40-60% with contingency management
Verified4Alcohol use disorder remission rate: 36% within one year with treatment
Directional5Cocaine addiction recovery: 50% relapse within 1 year post-treatment
Single source6Heroin users entering treatment: average 7 years of use prior
Verified7Buprenorphine treatment reduces opioid overdose risk by 38%
Verified8Cannabis use disorder affects 10% of regular users, 16% of daily users
Verified9U.S. behavioral health treatment facilities: 17,581 serving 5 million annually
Directional10Nicotine addiction treatment success: 25-30% long-term quit rate with varenicline
Single source11MDMA-assisted therapy for PTSD: 67% remission rate in phase 3 trials
Verified12Inhalant addiction recovery challenging, with 50% relapse in first month
Verified13Kratom withdrawal similar to opioids, treated with buprenorphine in 70% cases
Verified14LSD tolerance develops rapidly, but psychological dependence low at 5%
Directional15Contingency management boosts stimulant treatment retention by 50-100%
Single source16MAT for alcohol (naltrexone) reduces heavy drinking days by 25%
VerifiedAddiction and Treatment Interpretation
These statistics paint a stark picture of a nation struggling with addiction, where proven treatments like medication and contingency management are woefully underutilized lifelines that we must urgently extend to more people.
Economic Costs
1Illicit drug use costs the U.S. $740 billion annually in healthcare, crime, and lost productivity
Verified2Opioid crisis economic burden: $1.02 trillion in U.S. from 2015-2020
Verified3Alcohol misuse costs U.S. $249 billion yearly in healthcare and lost productivity
Verified4Methamphetamine economic impact: $23.4 billion annually in U.S. healthcare and crime
Directional5Cocaine production and trafficking generate $88 billion in global illicit revenue yearly
Single source6U.S. prescription opioid misuse costs $78.5 billion per year in healthcare alone
Verified7Global cannabis market illicit value: $75 billion annually
Verified8Heroin-related crime costs U.S. $50 billion annually in enforcement and victimization
Verified9Treatment for substance use disorders costs U.S. $42 billion yearly
Directional10Lost productivity from drug use disorders: 194 million lost workdays in U.S. annually
Single source11Fentanyl crisis adds $1,500 per capita healthcare cost in high-burden U.S. states
Verified12Global amphetamines trafficking revenue: $40 billion per year
Verified13MDMA/ecstasy market value: $5-10 billion globally illicit sales annually
Verified14Inhalant-related emergency visits cost U.S. $2.5 billion yearly
Directional15Kratom-related hospitalizations cost $50 million annually in U.S.
Single source16Workplace drug testing saves U.S. employers $1 billion yearly in accident prevention
Verified17U.S. spends $15 billion annually on drug-related incarceration
VerifiedEconomic Costs Interpretation
America's addictions are essentially running a monstrous, trillion-dollar shadow economy where the only products are ruin, the only growth is in suffering, and every citizen is an unwitting shareholder footing the bill.
Health Impacts
1Fentanyl-involved overdose deaths rose 22% from 2021 to 2022, totaling 73,838 in the U.S.
Verified2Opioid use disorder led to 81,806 overdose deaths in the U.S. in 2022
Verified3Methamphetamine-involved overdose deaths increased to 36,466 in the U.S. in 2022
Verified4Cocaine overdose deaths reached 27,569 in the U.S. in 2022, up 8% from prior year
Directional5Alcohol contributes to 178,000 annual deaths in the U.S., including 49% of liver disease deaths
Single source6Cannabis use associated with 22% increased risk of schizophrenia in genetically predisposed youth
Verified7Heroin injection leads to HIV infection in 9% of U.S. users annually without prevention
Verified8Benzodiazepine misuse triples risk of opioid overdose death, per U.S. studies
Verified9Chronic methamphetamine use causes 40-50% dopamine transporter loss in brain scans
Directional10MDMA use linked to 3.2-fold increase in depression risk long-term
Single source11Prescription opioid misuse initiates 80% of heroin users' opioid journeys in U.S.
Verified12Inhalant abuse causes sudden death in 100-125 U.S. teens annually via cardiac arrhythmia
Verified13Kratom overdose deaths rose to 1,805 in the U.S. from 2017-2021, often polydrug
Verified14LSD rarely causes direct overdose but flashbacks persist in 20% of heavy users
Directional15U.S. drug overdose deaths totaled 109,680 in 2023, 75% involving synthetic opioids like fentanyl
Single sourceHealth Impacts Interpretation
It appears we are hosting a grim Olympics where the medals are measured in body counts and the only record we keep breaking is our own national tragedy.
Legal and Policy
1U.S. federal drug arrests totaled 1.2 million in 2022, mostly possession
Verified242 U.S. states legalized medical cannabis by 2023, covering 93% population
Verified3DEA Schedule I drugs include heroin, LSD, marijuana, ecstasy per Controlled Substances Act
Verified4Global opium production hit 6,800 tons in 2022, mainly Afghanistan
Directional5U.S. opioid prescribing declined 44% from 2011 peak to 2022
Single source624 states have decriminalized small amounts of drugs as of 2023
Verified7Fentanyl declared Schedule I, but analogs challenge enforcement
Verified8International treaties like 1961 UN Single Convention control 330 drugs
Verified9U.S. spends $47 billion yearly on drug law enforcement
Directional10Portugal's 2001 decriminalization reduced overdose deaths by 80% per capita
Single source11Cannabis legalization in Canada led to 35% drop in illegal market share by 2022
Verified12Methamphetamine precursors like pseudoephedrine regulated under Combat Meth Act 2005
Verified13Psychedelic therapy legalization efforts: Oregon Measure 109 passed 2020 for psilocybin
Verified14U.S. needle exchange programs operate in 37 states despite federal restrictions
Directional15Global cocaine seizures: 1,400 tons in 2022, led by Colombia
Single sourceLegal and Policy Interpretation
The American legal landscape presents a bizarre contradiction, where a person can be federally arrested for possessing a plant that their state not only sells in stores but also prescribed by their doctor, all while our enforcement spending soars despite evidence that treating drugs as a health issue saves lives.
Prevalence and Usage
1In 2022, 70.4 million people aged 12 or older (24.9% of the U.S. population) reported past year misuse of prescription pain relievers
Verified2Globally, 296 million people used cannabis in 2021, representing 5.8% of the adult population aged 15-64
Verified3In the United States, 48.7 million people aged 12 or older (17.3%) used illicit drugs in the past year in 2022
Verified4Lifetime prevalence of cocaine use among U.S. adults aged 12+ reached 22.8 million people (8.1%) in 2022
Directional5Methamphetamine use disorder affected 2.5 million people worldwide in 2019
Single source6In Europe, 8.4 million adults aged 15-64 reported past-year cannabis use in 2022
Verified7Heroin use in the past year was reported by 828,000 U.S. individuals aged 12+ in 2022
Verified8Amphetamine-type stimulants were used by 34 million people globally in 2021 (0.7% of adults 15-64)
Verified9Past-month hallucinogen use among U.S. youth aged 12-17 was 1.1% (289,000 people) in 2022
Directional10Inhalant misuse in the past year affected 2.3 million U.S. people aged 12+ (0.8%) in 2022
Single source11Sedative misuse past year prevalence was 5.4 million (1.9%) among U.S. adults 12+ in 2022
Verified12Ecstasy/MDMA past-year use: 2.7 million U.S. people aged 12+ (1.0%) in 2022
Verified13Kratom use in past year: 1.7 million U.S. adults 12+ (0.6%) in 2022
Verified14LSD past-year use: 0.9 million U.S. people 12+ (0.3%) in 2022
Directional15Past-month alcohol use disorder affected 28.9 million U.S. people 12+ (10.2%) in 2022
Single source16Nicotine vaping past-month use among U.S. high school students: 10.0% in 2023
VerifiedPrevalence and Usage Interpretation
Our collective preoccupation with the substances we prohibit often distracts from the more pervasive, and often legally sanctioned, tragedies of alcohol and nicotine, revealing a society curiously adept at fighting some addictions while quietly drowning in others.
Sources & References
- Reference 1NIDAnida.nih.govVisit source
- Reference 2UNODCunodc.orgVisit source
- Reference 3SAMHSAsamhsa.govVisit source
- Reference 4WHOwho.intVisit source
- Reference 5EMCDDAemcdda.europa.euVisit source
- Reference 6CDCcdc.govVisit source
- Reference 7THELANCETthelancet.comVisit source
- Reference 8NCBIncbi.nlm.nih.govVisit source
- Reference 9DEAdea.govVisit source
- Reference 10KFFkff.orgVisit source
- Reference 11SHRMshrm.orgVisit source
- Reference 12ACLUaclu.orgVisit source
- Reference 13NATUREnature.comVisit source
- Reference 14BJSbjs.govVisit source
- Reference 15SENTENCINGPROJECTsentencingproject.orgVisit source
- Reference 16OJPojp.govVisit source
- Reference 17CATOcato.orgVisit source
- Reference 18CANADAcanada.caVisit source
- Reference 19OREGONoregon.govVisit source
- Reference 20NASAnasa.orgVisit source